BCL2L2 Antikörper
Kurzübersicht für BCL2L2 Antikörper (ABIN6940517)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified by Protein A/G
-
Immunogen
- Recombinant human full-length BCL2L2 protein
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Positive Control: PC-3, HEK293, HePG2, MCF-7, U87, Human colon extract, human spleen.
Known Application: Western Blot (1-2 μg/mL),Optimal dilution for a specific application should be determined.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- BCL2L2
-
Hintergrund
- BCLW promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
Molekulargewicht
- 22-30kDa
-
Gen-ID
- 599
-
UniProt
- Q92843
Target
-